The Tennessee Innovative Clinical Trials Network CTN2 has soared in just its first year of operations, evidencing the demand for clinical investigation networks in Tennessee. Launched in April of 2018, CTN2 has already secured contracts to work with more than six medical institutions across the state. It has even been able to launch studies and secure 23 Tennesseans patients in CTN2 trials.
The organization was launched as a 501(C)(3) subsidiary of the University of Tennessee Research Foundation (UTRF). The organization was created to enable the University of Tennessee Health Science Center (UTHSC), clinical research faculty, to design, solicit, and conduct robust statewide clinical trials with the overarching goal of providing a new therapeutics and medical devices aimed at improving the health of all Tennesseans.
The vision of Steve R. Goodman, Ph.D.
The vice chancellor of Research for UTHSC, Dr. Goodman, was quoted "CTN2 will provide robust statewide clinical trials that will improve medical treatments while providing UTHSC credit for the clinical trial contracts being performed by its faculty who are located at participating hospitals throughout the state."
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).